Mammalian cells proteolytically release (shed) the extracellular domains of many cell-surface proteins. Modification of the cell surface in this way can alter the cell's responsiveness to its environment and release potent soluble regulatory factors. The release of soluble tumour-necrosis factor-alpha (TNF-alpha) from its membrane-bound precursor is one of the most intensively studied shedding events because this inflammatory cytokine is so physiologically important. The inhibition of TNF-alpha release (and many other shedding phenomena) by hydroxamic acid-based inhibitors indicates that one or more metalloproteinases is involved. We have now purified and cloned a metalloproteinase that specifically cleaves precursor TNF-alpha. Inactivation of the gene in mouse cells caused a marked decrease in soluble TNF-alpha production. This enzyme (called the TNF-alpha-converting enzyme, or TACE) is a new member of the family of mammalian adamalysins (or ADAMs), for which no physiological catalytic function has previously been identified. Our results should facilitate the development of therapeutically useful inhibitors of TNF-alpha release, and they indicate that an important function of adamalysins may be to shed cell-surface proteins.

The ectodomains of numerous proteins are released from cells by proteolysis to yield soluble intercellular regulators. The responsible protease, tumor necrosis factor-alpha converting enzyme (TACE), has been identified only in the case when tumor necrosis factor-alpha (TNFalpha) is released. Analyses of cells lacking this metalloproteinase-disintegrin revealed an expanded role for TACE in the processing of other cell surface proteins, including a TNF receptor, the L-selectin adhesion molecule, and transforming growth factor-alpha (TGFalpha). The phenotype of mice lacking TACE suggests an essential role for soluble TGFalpha in normal development and emphasizes the importance of protein ectodomain shedding in vivo.

C57BL/6 mice genetically deficient in interleukin 15 (IL-15−/− mice) were generated by gene targeting. IL-15−/− mice displayed marked reductions in numbers of thymic and peripheral natural killer (NK) T cells, memory phenotype CD8+ T cells, and distinct subpopulations of intestinal intraepithelial lymphocytes (IELs). The reduction but not absence of these populations in IL-15−/− mice likely reflects an important role for IL-15 for expansion and/or survival of these cells. IL-15−/− mice lacked NK cells, as assessed by both immunophenotyping and functional criteria, indicating an obligate role for IL-15 in the development and functional maturation of NK cells. Specific defects associated with IL-15 deficiency were reversed by in vivo administration of exogenous IL-15. Despite their immunological defects, IL-15−/− mice remained healthy when maintained under specific pathogen-free conditions. However, IL-15−/− mice are likely to have compromised host defense responses to various pathogens, as they were unable to mount a protective response to challenge with vaccinia virus. These data reveal critical roles for IL-15 in the development of specific lymphoid lineages. Moreover, the ability to rescue lymphoid defects in IL-15−/− mice by IL-15 administration represents a powerful means by which to further elucidate the biological roles of this cytokine.

Bacterial pneumonia is an increasing complication of HIV infection and inversely correlates with the CD4+ lymphocyte count. Interleukin (IL)-17 is a cytokine produced principally by CD4+ T cells, which induces granulopoiesis via granulocyte colony-stimulating factor (G-CSF) production and induces CXC chemokines. We hypothesized that IL-17 receptor (IL-17R) signaling is critical for G-CSF and CXC chemokine production and lung host defenses. To test this, we used a model of Klebsiella pneumoniae lung infection in mice genetically deficient in IL-17R or in mice overexpressing a soluble IL-17R. IL-17R–deficient mice were exquisitely sensitive to intranasal K. pneumoniae with 100% mortality after 48 h compared with only 40% mortality in controls. IL-17R knockout (KO) mice displayed a significant delay in neutrophil recruitment into the alveolar space, and had greater dissemination of K. pneumoniae compared with control mice. This defect was associated with a significant reduction in steady-state levels of G-CSF and macrophage inflammatory protein (MIP)-2 mRNA and protein in the lung in response to the K. pneumoniae challenge in IL-17R KO mice. Thus, IL-17R signaling is critical for optimal production of G-CSF and MIP-2 and local control of pulmonary K. pneumoniae infection. These data support impaired IL-17R signaling as a potential mechanism by which deficiency of CD4 lymphocytes predisposes to bacterial pneumonia.

The amyloid protein, A␤, which accumulates in the brains of Alzheimer patients, is derived by proteolysis of the amyloid protein precursor (APP). APP can undergo endoproteolytic processing at three sites, one at the amino terminus of the A␤ domain (␤-cleavage), one within the A␤ domain (␣-cleavage), and one at the carboxyl terminus of the A␤ domain (␥-cleavage). The enzymes responsible for these activities have not been unambiguously identified. By the use of gene disruption (knockout), we now demonstrate that TACE (tumor necrosis factor ␣ converting enzyme), a member of the ADAM family (a disintegrin and metalloprotease-family) of proteases, plays a central role in regulated ␣-cleavage of APP. Our data suggest that TACE may be the ␣-secretase responsible for the majority of regulated ␣-cleavage in cultured cells. Furthermore, we show that inhibiting this enzyme affects both APP secretion and A␤ formation in cultured cells.The amyloid protein, A␤, which accumulates in the brains of Alzheimer patients, is derived by proteolysis of the amyloid protein precursor (APP) 1 (1-3). APP can undergo endoproteolytic processing at three sites, one at the amino terminus of the A␤ domain (␤-cleavage), one within the A␤ domain (␣-cleavage), and one at the carboxyl terminus of the A␤ domain (␥-cleavage). The enzymes responsible for these activities have not been unambiguously identified.In most cells in culture, a fraction (10 -30%) of all APP undergoes ␣-cleavage (4 -7). This results in the secretion of the large extracellular domain of APP into the medium. This secreted APP (APP s ) is a major APP-related species found in cerebrospinal fluid and brain homogenates (8,9) and is thought to interact with components of the extracellular matrix and with receptors on cells. In cultured cells it has been shown that the fraction of APP that is converted to APP s can be increased by activating second messenger cascades including those involving protein kinase C, protein kinase A, mitogen-activated protein kinase, protein phosphatase 1, protein phosphatase 2B (calcineurin), and calcium (4 -6, 10 -14). In most cells in culture, activating protein kinase C causes the majority (80 -95%) of the APP to undergo ␣-cleavage ("regulated" ␣-cleavage). Stimulation of APP s formation and secretion by activating second messenger cascades is not due to the phosphorylation of APP (15, 16) but may be due to protein phosphorylation leading to alterations in the trafficking of APP (17) or in the activity of an ␣-secretase. Importantly, stimulating ␣-cleavage of APP leads to a significant decrease in A␤ formation (18 -20).The potential importance of regulated cleavage of APP is indicated by the ability of acetylcholine, a critical neurotransmitter altered in Alzheimer's disease, working through muscarinic receptors, to stimulate regulated cleavage (4,10,21,22). Activation of other metabotropic receptors also leads to activation of regulated secretion of APP (4,21,23,24). Regulated cleavage of APP appears to occur in vivo under conditions in which protein ...